Daiichi exits Sun Pharma in India's largest bulk deal
Japanese firm raises $3.2 billion; Goldman Sachs, Singapore govt, Aranda lead stake buy; Sun stock dips 9%22-04-2015
22-04-2015
Sun Pharma rebounds after steep fall
The stock up 2% at Rs 971 on the National Stock Exchange.22-04-2015
Daiichi stake sale:Singapore govt arm, Goldman Sachs picksup Sun Pharma shares
Government of Singapore arm andGoldman Sachs have bought shares of Sun Pharma that wereoffloaded by Daiichi Sankyo through bulk deal on the NSE. Japanese pharmaceuticals compa...22-04-2015
Sun Pharma rebounds after Tuesday's fall
Sun Pharmaceutical Industries Ltd gained 2 per cent in the morning session on Wednesday, after falling 8.8 per cent on Tuesday. JP Morgan said it will use the weakness post Daiichi's sha...22-04-2015
Shanghvi did not buy Daiichi Sankyos shares: Sun Pharma
Drug major Sun Pharmaceutical today said its promoter and Managing Director Dilip Shanghvi did not buy shares of the company sold by the Japanese drugmaker Daiichi Sankyo....Dilip Shanghvi...22-04-2015
Sun Pharma says Shanghvi did not buy Daiichi shares
Rumours were that Sanghvi, who holds 9.61 per cent stake in Sun Pharma, had bought shares when Daiichi exited from the Indian firm.22-04-2015
Sun Pharma Rebounds on Value Buying, Stock Jumps Nearly 3%
The shares of Sun Pharma slumped 10 per cent in trades on Tuesday after Japan's Daiichi Sankyo sold its 8.9 per cent stake in India's biggest drugmaker at a discount.22-04-2015
Sun Pharma slips 9% as Daiichi Sankyo exits. Should you buy?
A combined 276.63 million shares representing 11.5% of total equity of Sun Pharma changed hands on the NSE and BSE21-04-2015
Why Daiichi's exit is good for Sun Pharma...
Splitting management bandwidth by investing in non-core businesses will not be appreciated by the market in the long run.21-04-2015
Daiichi exits Sun Pharma in India's largest bulk deal
Japanese firm raises $3.2 bn; Goldman Sachs, Singapore govt, Aranda lead stake buy; Sun stock dips 9%21-04-2015